Сauses of death in patients receiving program heamodalysis
- Authors: Rtishcheva OV1, Kalev OF1, Akhmatov VY.1
-
Affiliations:
- Issue: No 1 (2011)
- Pages: 43-45
- Section: Articles
- URL: https://journals.eco-vector.com/2075-3594/article/view/245950
- ID: 245950
Cite item
Full Text
Abstract
Aim. Assessment of causes of death in patients on program haemodialysis, based on demographic characteristics.
Methods. 88 patients on program haemodialysis, died from 2003 to 2010 years were analyzed.
Results. The leading cause of death was cardiovascular complications, but their role started to diminish since 2007. Women more oftener, than men, died from acute myocardial infarction and stroke. In younger age (16 - 45 years) main causes of death were chronic heart failure and stroke, but no acute myocardial infarctions were observed. In group age >45 years acute myocardial infarction was the third among leading causes of death (inferior to chronic heart failure and stroke.
Conclusion. Age and gender influence the structure of causes of death in patients on program haemodialysis.
Methods. 88 patients on program haemodialysis, died from 2003 to 2010 years were analyzed.
Results. The leading cause of death was cardiovascular complications, but their role started to diminish since 2007. Women more oftener, than men, died from acute myocardial infarction and stroke. In younger age (16 - 45 years) main causes of death were chronic heart failure and stroke, but no acute myocardial infarctions were observed. In group age >45 years acute myocardial infarction was the third among leading causes of death (inferior to chronic heart failure and stroke.
Conclusion. Age and gender influence the structure of causes of death in patients on program haemodialysis.
Keywords
References
- Moeller S., Gioberge S., Brown G. ESRD patients in 2001:global overview of patients,treatment modalities and developing trends. Nephrol Dial Transplant 2002; 17: 2071-2076.
- Бикбов Б.Т., Томилина Н.А. Состояние заместительной терапии больных с хронической почечной недосточностью в Российской Федерации в 1998-2007 гг. Нефрология и диализ 2009; 11(3): 194-195.
- Милованов Ю.С., Милованова Л.Ю., Добросмыслов И.А. Кардиопротективный эффект препаратов эпоэтина на преддиализных стадиях хронической болезни почек (2 часть). Лечащий врач 2010; 3:76-78.
- Волков М.М, Смирнов А.В., Добронравов В.А., и сооавт. Статус витамина D у пациентов с хронической болезнью почек и его связь с сердечно- сосудистой патологией. Нефрология 2009; Том 13; 2: 60-64.
- Minino A.M., Arias E., Kocbaner K.D. et al. Deaths: final data for 2000. National Vital Statistics Reports 2002;50: 1-120.
- Parfrey PS., Foley RN. The clinical epidemiology of cardiac disease in chronic renal failure. J Am Soc Nephrol 1999; 10:1606-1615.
- Ртищева О.В., Калев О.Ф. Возрастно- половые особенности показателей липидного обмена у больных, получающие лечение прграммным гемодиализом. Клиническая нефрология 2010; 4: 55-58.
- Ильичева О.Е., Харламова У.В. Некоронарогенные поражения миокарда. Учебное пособие. Челябинск. 2008. 55-57.
Supplementary files
